Elegant Technology for Renal Denervation Treatment

Cardiosonic develops pioneering solutions for transluminal high-intensity ultrasound ablation. The company’s flagship application, the TIVUS high-intensity, directional ultrasound catheter system enables remote, localized, controlled and repeatable thermal modulation of the renal vessel wall tissue, to perform safe therapeutic renal sympathetic denervation by ultrasound ablation, for resistant hypertension. Based on proven connection between hyper-activation of the sympathetic nervous system and the pathophysiology of hypertension, therapeutic renal sympathetic denervation has been shown to induce a reduction in blood pressure. With the potential to introduce a new standard of care, the TIVUS system technology addresses one of medicine’s most pressing challenges.

In preclinical trials, the company’s flagship TIVUS system has shown excellent results.